KR930702004A - 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법 - Google Patents

세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법

Info

Publication number
KR930702004A
KR930702004A KR1019930701448A KR930701448A KR930702004A KR 930702004 A KR930702004 A KR 930702004A KR 1019930701448 A KR1019930701448 A KR 1019930701448A KR 930701448 A KR930701448 A KR 930701448A KR 930702004 A KR930702004 A KR 930702004A
Authority
KR
South Korea
Prior art keywords
acid derivatives
compression method
tablets containing
direct compression
preparing tablets
Prior art date
Application number
KR1019930701448A
Other languages
English (en)
Other versions
KR100226386B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930702004A publication Critical patent/KR930702004A/ko
Application granted granted Critical
Publication of KR100226386B1 publication Critical patent/KR100226386B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019930701448A 1990-11-15 1991-11-08 직접압축에 의하여 세팔로스포란산 유도체를 함유하는 정제를 제조하는 방법 KR100226386B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9014210A FR2669221B1 (fr) 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
FR90/14210 1990-11-15
PCT/FR1991/000872 WO1992008463A1 (fr) 1990-11-15 1991-11-08 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique

Publications (2)

Publication Number Publication Date
KR930702004A true KR930702004A (ko) 1993-09-08
KR100226386B1 KR100226386B1 (ko) 1999-10-15

Family

ID=9402216

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701448A KR100226386B1 (ko) 1990-11-15 1991-11-08 직접압축에 의하여 세팔로스포란산 유도체를 함유하는 정제를 제조하는 방법

Country Status (11)

Country Link
US (1) US5514383A (ko)
EP (1) EP0557389B1 (ko)
JP (1) JP3253074B2 (ko)
KR (1) KR100226386B1 (ko)
AT (1) ATE111734T1 (ko)
CA (1) CA2094122C (ko)
DE (1) DE69104220T2 (ko)
DK (1) DK0557389T3 (ko)
ES (1) ES2060417T3 (ko)
FR (1) FR2669221B1 (ko)
WO (1) WO1992008463A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
AU4353996A (en) * 1994-12-14 1996-07-03 Bioglan Ireland (R & D) Limited Pharmaceutical tablet formulations for direct compression
EA001089B1 (ru) * 1996-02-29 2000-10-30 Фудзисава Фармасьютикал Ко., Лтд. ТАБЛЕТКИ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК, И СПОСОБ ИХ ИЗГОТОВЛЕНИЯ
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5735891A (en) * 1996-12-02 1998-04-07 Sulzer Intermedics Inc. Self-clamping anchoring sleeve
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
KR20030078105A (ko) * 2002-03-28 2003-10-08 (주)다산메디켐 제약 및 식품산업의 정제 제조시 반드시 거쳐야 하는공정인 타정(정제의 제조) 공정에서 타정을 위한 분체혼합물의 유동성을 개선하고 타정 공정시 발생되는타정장애 중 특히 타정물이 타정기 또는 타정펀치에 붙든현상인 점착성 발생을 없앤 제약산업에서 사용될 수 있는고형제제를 위한 직타용 부형제의 새로운 조성물에관한것이다.
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
US9149482B2 (en) * 2004-05-10 2015-10-06 Lupin Ltd. Pharmaceutical formulation of cefixime for enhanced bioavailability
CN110041346B (zh) * 2019-04-17 2022-06-07 广东立国制药有限公司 一种低成本的头孢克肟的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4708956A (en) * 1985-12-12 1987-11-24 Kyowa Hakko Kogyo Co., Ltd. 3-position halogenated cephalosporin analogs and pharmaceutical compositions
JPH01149728A (ja) * 1987-12-04 1989-06-12 Fujisawa Pharmaceut Co Ltd 抗潰瘍剤
JPH01242589A (ja) * 1988-03-22 1989-09-27 Fujisawa Pharmaceut Co Ltd セフエム化合物
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69104220T2 (de) 1995-01-26
FR2669221A1 (fr) 1992-05-22
ES2060417T3 (es) 1994-11-16
EP0557389A1 (en) 1993-09-01
JPH06502420A (ja) 1994-03-17
CA2094122A1 (fr) 1992-05-16
CA2094122C (fr) 2004-07-20
DK0557389T3 (da) 1994-10-17
DE69104220D1 (de) 1994-10-27
JP3253074B2 (ja) 2002-02-04
EP0557389B1 (fr) 1994-09-21
US5514383A (en) 1996-05-07
WO1992008463A1 (fr) 1992-05-29
FR2669221B1 (fr) 1993-01-15
KR100226386B1 (ko) 1999-10-15
ATE111734T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
SE9704545D0 (sv) Novel compounds
ES2017836A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK1032374T3 (da) Sphroider, fremgangsmåde og farmaceutiske præparater
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DE69532580D1 (de) Neue antagonistische verbindungen
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
IL113450A (en) Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby
DK1032391T3 (da) Sfæroider indeholdende tiagabin, fremstillingsproces og farmaceutisk sammensætning
BR9509975A (pt) Formulação farmacêutica
NO931905D0 (no) 8-en-19, 11beta-broede steroider, deres fremstilling og farmasoeytiske preparater inneholdende disse
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
AP9200443A0 (en) Heterocyclic compounds.
NO941084L (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
ES8504160A1 (es) Procedimiento para la preparacion de derivados de propan-2-ol
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi
DE69215085D1 (de) Aminoacylderivate von gem-diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
ATE213638T1 (de) Carbonyleisen-tablette durch direktverpressung
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
NO974687D0 (no) Kondenserte <beta>-carboliner

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040723

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee